Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 IL-6 inhibition and infection: treating patients with tocilizumab.

× No keyword cloud information.

6 in total

Review 1. Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Authors: Chia Chi Sun; Valentina Vaja; Jodie L Babitt; Herbert Y Lin
Journal: Am J Hematol Date: 2012-01-31 Impact factor: 10.047

2. IL-6-mediated signaling pathways limit Chlamydia muridarum infection and exacerbate its pathogenicity in the mouse genital tract.

Authors: Xin Sun; Qi Tian; Luying Wang; Min Xue; Guangming Zhong
Journal: Microbes Infect Date: 2017-08-31 Impact factor: 2.700

3. Does tocilizumab contribute to elevation of rheumatoid factor and induction of paradoxical syaloadenitis in rheumatoid arthritis patients?

Authors: Dušanka Martinović Kaliterna; Jure Aljinović; Dijana Perković; Daniela Marasović Krstulović; Ivanka Marinović; Tonko Vlak
Journal: Wien Klin Wochenschr Date: 2013-11-19 Impact factor: 1.704

4. Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya.

Authors: Reena Shah; Jasmit Shah; Jaimini Gohil; Gunturu Revathi; Salim Surani
Journal: Int J Gen Med Date: 2022-03-03

Review 5. Insights Into Host Cell Cytokines in Chlamydia Infection.

Authors: Wenjing Xiang; Nanyan Yu; Aihua Lei; Xiaofang Li; Shui Tan; Lijun Huang; Zhou Zhou
Journal: Front Immunol Date: 2021-05-21 Impact factor: 7.561

Review 6. SARS-CoV-2 Associated Immune Dysregulation and COVID-Associated Pulmonary Aspergilliosis (CAPA): A Cautionary Tale.

Authors: Dominic Adam Worku
Journal: Int J Mol Sci Date: 2022-03-17 Impact factor: 5.923

6 in total